Five Prime Therapeutics Inc. (FPRX) Fundamentals

Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. It is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in the pipeline: Cabiralizumab, FPA150, FPT155, and Bemarituzumab.
SHARE INFORMATION
Market CapUS$ 1.769.737.102
Shares Outstanding46.572.029
Float39.701.210
Percent Float85,25%
Short Interest2.973.047,00
Short Percent Float6,4%
Short Interest Ratio0,76
Short Interest Date2021-03-31
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 13.178.000
Latest Fiscal EPSUS$ -2,29
Latest Fiscal Date2020-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions322
Institutional Holdings Date2021-03-31
Institutional Bought Previous 3 Months9.941.412
Institutional Holdings Percent140,7%
Institutional Sold Previous 3 Months11.799.799
Insider Holdings Date2021-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2,9
Insider Sold Previous 3 Months23.539
Insider Shares Owned1.335.081
TRADING INFO
52 Week HighUS$ 0,00
52 Week LowUS$ 0,00
52 Week High ChangeUS$ 0,00
21 Day Moving AverageUS$ 0,00
21 Day Extended Moving AverageUS$ 38,00
50 Day Moving AverageUS$ 0,00
50 Day Extended Moving AverageUS$ 37,9942
200 Day Moving AverageUS$ 0,00
200 Day Extended Moving AverageUS$ 34,5804
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha0.002087
Beta4.5726
Standard Deviation0.504063
R20.187263
7 Day Price ChangeUS$ 0,00
7 Day Percent Change0,0%
21 Day Price ChangeUS$ 0,00
21 Day Percent Change0,0%
30 Day Price ChangeUS$ 0,00
30 Day Percent Change0,0%
Month to Date Price ChangeUS$ 0,00
Month to Date Percent Change0,0%
Quarter to Date Price ChangeUS$ 0,00
Quarter to Date Percent Change0,0%
180 Day Price ChangeUS$ 0,00
180 Day Percent Change0,0%
200 Day Price ChangeUS$ 0,00
200 Day Percent Change0,0%
Year to Date Price ChangeUS$ 0,00
Year to Date Percent Change0,0%

Five Prime Therapeutics Inc. (FPRX) Key Ratios

PROFITABILITY
EBIT Margin-602,4%
EBITDA Margin-578,0%
Pre-Tax Profit Margin-517,1%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 4.764.000
Revenue Per ShareUS$ 0,1023
Revenue (3 Years)US$ -44,28
Revenue (5 Years)US$ -41,52
FINANCIAL STRENGTH
Price to Tangible Book6,70
Total Debt To Equity0,20
Int Coverage0,00
Current Ratio13,20
Leverage Ratio1,30
Quick Ratio13,00
Long Term Debt To Capital0,14
VALUATION MEASURES
PE Ratio-16,60
Enterprise ValueUS$ 1.529.912.102
Price to Sales371,4813
Price to Free Cash-35,70
PE High Last 5 Years6,60
Price To Book6,70
Price To Cash Flow4,80
PE Low Last 5 Years-8,10
Price to Tangible Book6,70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,80
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-30,35
Return on Equity-40,58
Return on Capital-51,96

Five Prime Therapeutics Inc. (FPRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOThomas Civik
Emplyoees51
Last AuditUQ
CIK0001175505
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address111 Oyster Point Boulevard
South San Francisco, CA 94080
Websitehttp://www.fiveprime.com
Facsimile+1 415 365-5601
Telephone+1 415 365-5600
Emailir@fiveprime.com
Seu Histórico Recente
NASDAQ
FPRX
Five Prime..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220524 01:54:31